Select a State

Global health R&D delivers for Rhode Island

US government investment in global health R&D has delivered

$23.9 million
to Rhode Island research institutions
250+ new jobs
for Rhode Island

Neglected diseases in Rhode Island

Chikungunya cases
62
Dengue cases
23
HIV diagnoses
845
Malaria cases
85
Tuberculosis cases
226
West Nile cases
9
Zika cases
58

Rhode Island's top USG-funded global health R&D institutions

Rhode Island Hospital
$10.6 million
University of Rhode Island
$5.7 million
Miriam Hospital
$5.0 million
Brown University
$2.6 million
Gordon Research Conferences
$49 thousand

Rhode Island industry in global health R&D

Amgen
Location(s):
West Greenwich
EpiVax
Location(s):
Providence
Particle Sciences
Location(s):
Bethlehem
Prothera Biologics
Location(s):
East Providence
Roger Williams Medical Center
Location(s):
Providence

Rhode Island's top areas of global health R&D by USG funding

11.8%
HIV/AIDS
25.2%
Malaria
1.8%
Tuberculosis
2.7%
Diarrheal diseases
47.4%
Neglected tropical diseases
Dengue
Helminths
Kinetoplastids
11.0%
Other
Hepatitis C
Non-allocable

Global health R&D at work in Rhode Island

Rhode Island Hospital’s Center for International Health Research (CIHR) is working on solutions to two of the world’s two most devastating parasitic diseases. Of all parasitic infections, malaria is the leading killer. Efforts at CIHR have yielded three vaccine candidates in the development pipeline. Second only to malaria is schistosomiasis, an infection of flatworms that damages human organs and impairs development in children. While it can be treated, a vaccine is badly needed. CIHR and partners have developed a vaccine candidate that works in mice and is showing promise in water buffalo, a major transmitter.

Footnotes